8legs: Frontiers in neuroscience

Your Followed Topics

#1 out of 2206.7K est. views99.30%

A case study reports temporary cognitive gains in an 80-year-old woman with advanced dementia after a high-dose psilocybin treatment.
Researchers administered 5 grams of Enigma strain mushrooms, with about 20 hours before notable functional gains appeared.
The study notes improvements spanned continence, ambulation, autonomous dressing, and social interaction.
Experts caution the findings do not reverse Alzheimer’s pathology, but suggest latent capacities may briefly become accessible.
The report stresses the observation is exploratory and calls for more controlled investigations.
Psilocybin’s effects on brain networks are a focus of prior research in mental health.
The case report appeared in Frontiers in Neuroscience and describes observational findings.
The participant reportedly showed improved verbal and motor functions after treatment.
Study emphasizes this is not a cure and must be interpreted cautiously.
Researchers highlight the need for systematic investigation to validate potential benefits.

Vote 0

#2 out of 2

A Brazilian case study reports a 5-gram psilocybin dose led to temporary improvements in speech and continence in an elderly Alzheimer’s patient.
Researchers conducted a second 3-gram dose a month later, with ongoing expressive gains noted during the session.
The authors say the report is observational and should generate hypotheses for future controlled investigations.
Background context notes ongoing global interest, with trials examining psilocybin’s effects on depression and cognitive symptoms in older adults.
Experts caution that this dose is far higher than typical clinical trials and carries risks.
A pilot clinical trial is evaluating psilocybin's potential to improve quality of life in people with mild cognitive impairment or early-stage Alzheimer's disease.
Neuroscientist Albert Garcia-Romeu notes potential benefits of psychedelic therapies for depression and anxiety in some patients.
The case report emphasizes careful interpretation and calls for systematic investigation in future trials.
The study notes that measures of sleep or brain activity were not monitored during the trips.
Researchers observed improvements in facial expressivity, emotional reciprocity, and gait during the second session.
The case involved a patient described as an elderly woman with dementia in her 80s receiving supervised dosing in Brazil.

Vote 0

Unlimited Access

Personalized Feed

Full Experience

By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.

Create an account and enjoy content that interests you with your personalized feed

Unlimited Access

Personalized Feed

Full Experience

By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.